Full-Time

RF Electrical Engineer

Posted on 6/18/2024

Promaxo

Promaxo

51-200 employees

Provides compact MRI solutions for urology

Biotechnology
Healthcare

Compensation Overview

$80k - $130kAnnually

Junior, Mid

Oakland, CA, USA

Category
Electrical Engineering
RF and Microwave Engineering
Required Skills
Oscilloscope

You match the following Promaxo's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree in Electrical Engineering or closely related field with preference given with at least 2 years of relevant R&D lab experience or Master’s degree in Electrical Engineering.
  • Knowledge and experience using standard electrical and RF test tools including network analyzer, oscilloscopes, function generators, bench power suppliers, digital multimeters
  • Knowledge of (Build Experience is a bonus) RF circuits/sensors such as matching networks, phase shifters, RF/MW antennae or MRI RF Coils
  • Knowledge of RF low noise signal amplifiers and RF power amplifiers
  • Understanding of RF electromagnetic fields and antennae
  • Effective technical communicator
  • Ability to manage action items and deliver according to a schedule
  • Fundamentals in math & sciences: mechanics, electronics, basic electromagnetic theory, etc.
  • Creative and resourceful.
Responsibilities
  • Design and build new RF magnetic field sensor coils for the MRI applications
  • Create schematics and layout PCBAs using Altium Designer software or equivalent
  • Bring up and test your PCBAs in the lab
  • Work with fab and assembly suppliers to get boards fabricated and assembled
  • Optimize your design by doing circuit analysis and choosing parts
  • Troubleshoot and resolve hardware issues in the factory and from the field
  • Work with mechanical engineers & electrical engineers to create industry-leading medical devices
  • Stay abreast with existing and emerging technologies, best practices and lessons learned, skill set requirements, and implementation options for our technology.
  • Understand the schedule, cost, and performance implications of hardware engineering cycles.

Promaxo provides MRI solutions specifically designed for prostate imaging and image-guided biopsies. Their MRI systems are compact and modular, allowing private medical practices, especially those in urology, to perform scans on-site without the need for extensive facility upgrades. This setup reduces the time patients wait for scans and follow-up visits, enhancing the quality of care and reducing anxiety. Promaxo's technology uses low magnetic fields to generate high-quality images quickly and comfortably for patients. The company differentiates itself from competitors by offering a cost-effective solution with low capital and operating costs, enabling clinics to recover their investment in less than a year. Promaxo's goal is to make MRI technology more accessible and affordable, ultimately improving patient care.

Company Size

51-200

Company Stage

Seed

Total Funding

$48.1M

Headquarters

Oakland, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Promaxo's compact MRI systems reduce patient wait times and improve care efficiency.
  • The company benefits from existing CPT codes, aiding quick capital cost recovery.
  • Promaxo's strong IP portfolio with 60 patents supports its innovative edge.

What critics are saying

  • Increased competition in the portable MRI market may impact Promaxo's market share.
  • Reliance on AI systems exposes Promaxo to data privacy and regulatory compliance risks.
  • Expansion into new markets may strain operational resources and create logistical challenges.

What makes Promaxo unique

  • Promaxo offers the first FDA-cleared portable MRI for prostate biopsy and treatment.
  • Their MRI systems require no extensive facility upgrades, unlike traditional MRI systems.
  • Promaxo's technology integrates AI and robotics for enhanced patient care and diagnostics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health

Family

Community Activties

Convenience

Time Away

Growth

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

2%
PR Newswire
Jun 18th, 2024
Zynext Ventures, The Vc Arm Of Zydus Lifesciences, Announces Investment In Promaxo: Pioneering Point-Of-Care Medical Imaging And Interventions With Next Generation Mri Systems

PENNINGTON, N.J., June 18, 2024 /PRNewswire/ -- Zynext Ventures USA LLC (Zynext Ventures), the Venture Capital (VC) arm of Zydus Lifesciences, dedicated to fostering disruptive healthcare innovations, announced its investment in Promaxo Inc. (Promaxo), a leading US-based developer of portable low-field MRI systems and minimally invasive robotics.Promaxo's innovative technology aims to revolutionize patient care by enabling point-of-care imaging and intervention. Their portable low-field MRI systems enable early diagnosis and treatment in a wider range of healthcare settings. The portable Promaxo MRI system is the first in the USA to receive an FDA 510(k) clearance for prostate biopsy and treatment. Unlike traditional MRI, the Promaxo MRI is open and compact with a limited fringe field and can be placed in a clinic or operating room. The system is also designed to be compatible with robotic procedures

U.S. Securities and Exchange Commission
Apr 14th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

IABC Nashville
Nov 24th, 2023
Global Hybrid Operating Room Equipment Market Report 2023-2028 - Surgical Oncology and Aesthetic Surgery are Key Applications Set to Increase the Adoption of HORs During the Forecast Period

Further, in June 2022, Promaxo Inc. launched an in-office MRI system-a single-sided MRI integrated with an AI-based imaging system-at East Valley Urology Centre.

eNews Park Forest
Nov 20th, 2023
Promaxo Announces Participation in the 35th Annual Piper Sandler Healthcare Conference

Promaxo was founded by a team of entrepreneurs and healthcare innovators to develop a minimally-invasive and patient-centric MRI and robotic platform.

Benzinga
Oct 4th, 2023
Promaxo Receives Direct Investment From Surgical Robotics Industry Pioneer Fred Moll And Announces Appointment As Strategic Advisor

OAKLAND, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Promaxo, Inc. ("Promaxo" or the "Company"), a medical imaging, robotics, and AI technology company, announced today that it has received a direct investment from Fred Moll, M.D., industry pioneer and leader in surgical robotics and minimally invasive surgery, with more than 40 years of experience of building and leading innovative medical device companies. Promaxo also appointed Dr. Moll as strategic advisor."Renowned for his extraordinary track record of success in innovating, developing, and commercializing novel technologies in the field of medical robotics, we are proud to announce that Promaxo has received a direct investment from Dr. Moll, who also joins us as a strategic advisor," said Dr

INACTIVE